Fig. 5From: Development and validation of a predictive model based on clinical and MpMRI findings to reduce additional systematic prostate biopsyDecision curves of the risk prediction models for the development (a) and validation cohorts (b). Model 1 = clinical model, model 2 = MRI model, and model 3 = combined model. The risk thresholds range from 0 to 100%Back to article page